FDA update 2016 - Fremont 2016 Webinar on Latest FDA Update and Expectations
Date2016-09-07
Deadline2016-09-06
VenueFremont, USA - United States
KeywordsLatest Update in fda; Health consequences of food; FDA guidance requirements
Websitehttps://bit.ly/29UxHiW
Topics/Call fo Papers
Overview:
The Food and Drug Administration Modernization Act (FDAMA) requires that manufacturers track certain devices when the agency orders them to do so.
Tracking is intended to facilitate notification and recall in the event a device presents a serious risk to health that requires prompt attention. The tracking provisions enacted by SMDA required mandatory tracking even if FDA did not issue an order. Specifically, section 519(e), as added by SMDA, required manufacturers to track if they were registered with FDA under section 510 of the act and engaged in the manufacturer of a device if its failure would be reasonably likely to have serious adverse health consequences, and if that device was either a permanently implantable device or a life-sustaining or life-supporting device used outside a device user facility.
Areas Covered In the Session:
Review the key provisions in the updated FDA guidance on medical device tracking
Understand the regulatory expectations for device tracking
Identify new terms and criteria
Understand the statutory criteria and what changed
Who Will Benefit:
This webinar will provide an overview and guidance to device manufacturers involved in medical device tracking activities. Employees who will benefit include:
All levels of management and departmental representatives and those who desire a better understanding or a "refresh" overview of the Medical Device Tracking process and FDA’s latest expectations
Regulatory Affairs
Clinical Affairs
Quality and Compliance
Marketing & Sales
Distributors/Authorized Representatives
Consultants
Speaker Profile:
David R. Dills , Global Regulatory Affairs & Compliance Consultant, has an accomplished record with more than 26 years of experience within regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVDs, and bio/pharmaceutical manufacturers on the global landscape.
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
http://www.compliance4all.com/
Event Link : http://bit.ly/29UxHiW
Twitter Follow us ? https://twitter.com/compliance4all
Facebook Like us ? https://www.facebook.com/Compliance4all
Pinterest - https://in.pinterest.com/compliance4all/
The Food and Drug Administration Modernization Act (FDAMA) requires that manufacturers track certain devices when the agency orders them to do so.
Tracking is intended to facilitate notification and recall in the event a device presents a serious risk to health that requires prompt attention. The tracking provisions enacted by SMDA required mandatory tracking even if FDA did not issue an order. Specifically, section 519(e), as added by SMDA, required manufacturers to track if they were registered with FDA under section 510 of the act and engaged in the manufacturer of a device if its failure would be reasonably likely to have serious adverse health consequences, and if that device was either a permanently implantable device or a life-sustaining or life-supporting device used outside a device user facility.
Areas Covered In the Session:
Review the key provisions in the updated FDA guidance on medical device tracking
Understand the regulatory expectations for device tracking
Identify new terms and criteria
Understand the statutory criteria and what changed
Who Will Benefit:
This webinar will provide an overview and guidance to device manufacturers involved in medical device tracking activities. Employees who will benefit include:
All levels of management and departmental representatives and those who desire a better understanding or a "refresh" overview of the Medical Device Tracking process and FDA’s latest expectations
Regulatory Affairs
Clinical Affairs
Quality and Compliance
Marketing & Sales
Distributors/Authorized Representatives
Consultants
Speaker Profile:
David R. Dills , Global Regulatory Affairs & Compliance Consultant, has an accomplished record with more than 26 years of experience within regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVDs, and bio/pharmaceutical manufacturers on the global landscape.
Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support-AT-compliance4All.com
http://www.compliance4all.com/
Event Link : http://bit.ly/29UxHiW
Twitter Follow us ? https://twitter.com/compliance4all
Facebook Like us ? https://www.facebook.com/Compliance4all
Pinterest - https://in.pinterest.com/compliance4all/
Other CFPs
- Fremont 2016 Webinar on Sanitation Chemical Testing - Best Practices
- International Conference on Studies in Arts, Humanities and Social Sciences (SAHSS-2017)
- The 2nd Int'l Conference on Cardiovascular Medicine (ICCM 2016)
- The 2nd Int'l Conference on Diabetes Mellitus (ICDM 2016)
- The 3rd Neurology and Neurosurgery Conference (NeuroConf 2016)
Last modified: 2016-07-29 15:35:36